Prosper N. Boyaka on Muck Rack

Prosper N. Boyaka

As seen in: Nature, The Journal of Immunology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Prosper N.

Contact Prosper N., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Three SARS-CoV-2 spike protein variants delivered intranasally by measles and mumps vaccines are broadly protective - Nature Communications

|
By Mohamed M. Shamseldin, John Evans, Chengjin Ye, Luis Martinez-Sobrido, Jacob Yount, Prosper N. Boyaka, Shan-Lu Liu, Mark Peeples, Sung J. Yoo
| Nature Verified
Abstract As the new SARS-CoV-2 Omicron variants and subvariants emerge, there is an urgency to develop intranasal, broadly protective vaccines. Here, we developed highly efficacious, intranasal trivalent SARS-CoV-2 vaccine candidates (TVC) based on three components of the MMR vaccine: measles virus (MeV), mumps virus (MuV) Jeryl Lynn (JL1) strain, and MuV JL2 strain.
Open in Who Shared Issue with article?

Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems

|
By Prosper N. Boyaka
| The Journal of Immunology Verified
Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems Prosper N. Boyaka The Journal of Immunology July 1, 2017, 199 (1) 9-16; DOI: 10.4049/jimmunol.1601775
Open in Who Shared Issue with article?
See all 2 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified